GlassScriptPhysician profile
Vance J Weber
NPI 1548255904
$2,283.41
in general payments reported to CMS, 2019-2025
33 companies · $389 in 2025
The $389 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $303 · 2020: $166 · 2021: $327 · 2022: $396 · 2023: $416 · 2024: $287 · 2025: $389.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,092.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,091.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $441.13 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $239.32 | 2019-2025 | |
| Novo Nordisk INC | $182.04 | 2022-2025 | Wegovy, Rybelsus, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $167.93 | 2019-2025 | Jardiance |
| Edwards Lifesciences Corporation | $150.31 | 2025 | Sapien 3 Ultra Resilia |
| Merck Sharp & Dohme LLC | $131.69 | 2021-2025 | Verquvo, Capvaxive |
| Amarin Pharma, INC. | $99.96 | 2019-2023 | |
| Pfizer INC. | $89.97 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $81.10 | 2020-2022 | |
| Baxter Healthcare | $75.49 | 2023-2024 | Hillrom - Cardiac Ambulatory Monitor |
| Abbott Laboratories | $65.53 | 2020-2022 | |
| Heartflow, INC. | $60.92 | 2023-2024 | Ffrct |
| Alnylam Pharmaceuticals INC. | $44.60 | 2022-2023 | Onpattro |
| E.R. Squibb & Sons, L.L.C. | $41.78 | 2019-2025 | Camzyos |
| Astrazeneca Pharmaceuticals LP | $40.44 | 2019-2023 | Farxiga |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $30.14 | 2023-2024 | |
| Amryt Pharma Holdings LTD | $29.84 | 2021 | |
| Sanofi-Aventis U.S. LLC | $29.26 | 2019-2024 | |
| Irhythm Technologies, INC. | $27.63 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $27.48 | 2022-2024 | |
| Althera Pharmaceuticals LLC | $26.60 | 2021 | |
| Atricure, INC. | $23.65 | 2025 | Atriclip Laa Exclusion System |
| Boston Scientific Corporation | $21.80 | 2024 | Watchman Flx |
| Impulse Dynamics (USA) INC. | $18.94 | 2022 | |
| Cvrx, INC. | $18.45 | 2024 | Barostim Neo System |
| Regeneron Healthcare Solutions, INC. | $17.00 | 2023 | Evkeeza |
| Esperion Therapeutics, INC. | $15.76 | 2024 | Nexletol |
| Azurity Pharmaceuticals, INC. | $15.34 | 2023 | Edarbi |
| Lexicon Pharmaceuticals, INC. | $15.09 | 2024 | |
| Arbor Pharmaceuticals, INC. | $13.81 | 2021 | |
| Lundbeck LLC | $13.78 | 2020 | |
| Akcea Therapeutics, INC. | $13.73 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $12.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vance Weber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.